Skip to main navigation Skip to search Skip to main content

Heterogenous treatment effects following inspiratory muscle training during recovery from post-acute COVID-19 syndrome

  • Richard S. Metcalfe
  • , Paul A. Swinton
  • , Kelly A. Mackintosh
  • , Ronan M. G. Berg
  • , James Shelley
  • , Zoe L. Saynor
  • , Joanne Hudson
  • , Jamie Duckers
  • , Keir Lewis
  • , Gwyneth A. Davies
  • , Melitta A. McNarry

    Research output: Contribution to journal › Article › peer-review

    85 Downloads (Pure)

    Abstract

    Purpose: To investigate whether heterogeneous treatment effects occur for changes in inspiratory muscle strength, perceived dyspnoea, and health-related quality of life (QoL), following eight-weeks unsupervised home-based inspiratory muscle training (IMT) in adults with post-acute COVID-19 syndrome.

    Methods: In total, 147 adults with self-reported prior COVID-19 either completed an eight-week home-based IMT intervention (n = 111; 92 females; 48 ± 11 years; 9.3 ± 3.6 months post-acute COVID-19 infection) or acted as “usual care” wait list controls (n = 36; 34 females; 49 ± 12 years; 9.4 ± 3.2 months post-acute COVID-19 infection).

    Results: Applying a Bayesian framework, we found clear evidence of heterogeneity of treatment response for inspiratory muscle strength: the estimated difference between standard deviations (SDs) of the IMT and control groups was 22.8 cmH2O (75% Credible Interval (CrI): 4.7-37.7) for changes in maximal inspiratory pressure (MIP), and 86.8 pressure time-units (PTUs; 75% CrI: 55.7-116.7) for sustained MIP (SMIP). Conversely, there were minimal differences in the SDs between the IMT and the control group for changes in perceived dyspnoea and health-related QoL, providing no evidence of heterogeneous treatment effects. Higher cumulative power during the IMT intervention was related to changes in MIP (ß = 10.9 [95% CrI: 5.3-16.8] cmH2O per 1SD) and SMIP (ß = 63.7 [32.2-95.3] PTUs per 1SD), clearly indicating an IMT dose response for changes in inspiratory muscle strength. Older age (>50 years), a longer time post-acute COVID-19 (>3 months), and greater severity of dyspnoea at baseline were also associated with smaller improvements in inspiratory muscle strength.

    Conclusions: Heterogenous individual responses occurred following an eight-week home-based IMT programme in people with post-acute COVID-19 syndrome. Consistent with standard exercise theory, larger improvements in inspiratory muscle strength are strongly related to a greater cumulative dose of IMT.
    Original languageEnglish
    Pages (from-to)1761-1769
    JournalMedicine and Science in Sports & Exercise
    Volume55
    Issue number10
    Early online date12 May 2023
    DOIs
    Publication statusPublished - 1 Oct 2023

    Keywords

    • post-acute covid-19 syndrome
    • long covid
    • rehabilitation
    • treatment
    • breathlessness
    • breathing

    Fingerprint

    Dive into the research topics of 'Heterogenous treatment effects following inspiratory muscle training during recovery from post-acute COVID-19 syndrome'. Together they form a unique fingerprint.

    Cite this